GB191414365A - Improved Manufacture of Agents for Reducing Blood Pressure. - Google Patents
Improved Manufacture of Agents for Reducing Blood Pressure.Info
- Publication number
- GB191414365A GB191414365A GB191414365DA GB191414365A GB 191414365 A GB191414365 A GB 191414365A GB 191414365D A GB191414365D A GB 191414365DA GB 191414365 A GB191414365 A GB 191414365A
- Authority
- GB
- United Kingdom
- Prior art keywords
- blood pressure
- reducing blood
- agents
- gelatine
- organisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
14,365. Zuelzer, G. June 20, 1913, [Convention date]. Bacterial products; bacteria, preparations for administering.-Preparations for reducing blood pressure are obtained by introducing into gelatine non-pathogenic micro-organisms which produce endotoxines, which organisms have previously been charged with amboceptors. In an example, the Bacillus coli, after passage culture through rabbits, is treated with a serum containing its amboceptor, washed, and introduced into gelatine. Other bacteria which may be used after being rendered non-pathogenic are those of the typhoid-hog-cholera, and the hµmorrhagic septicaemia groups.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE191414365X | 1913-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB191414365A true GB191414365A (en) | 1916-03-23 |
Family
ID=32523684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB191414365D Expired GB191414365A (en) | 1913-06-20 | 1914-06-15 | Improved Manufacture of Agents for Reducing Blood Pressure. |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB191414365A (en) |
-
1914
- 1914-06-15 GB GB191414365D patent/GB191414365A/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rogers | Bacterial growth and the cell envelope | |
| Stonier | Agrobacterium tumefaciens Conn II: Production of an antibiotic substance | |
| Cohn et al. | Terminology of enzyme formation | |
| Palmer Jr et al. | Mutualism versus independence: strategies of mixed-species oral biofilms in vitro using saliva as the sole nutrient source | |
| Tonin et al. | Beta-lactam-specific resistant mutants of Staphylococcus aureus | |
| Lantz et al. | Interactions of Bacteroides gingivalis with fibrinogen | |
| FI922825A0 (en) | Process for the preparation of a pharmaceutical preparation for controlling pathogenic microorganisms | |
| Paul et al. | Production and properties of an extracellular bacteriocin from Streptococcus mutans bacteriocidal for group A and other streptococci | |
| Cadoz et al. | Treatment of Purulent Meningitis with a New Cephalosporin–Rocephinº (Ro 13–9904) | |
| Waldvogel et al. | Collagenolytic activity of bacteria | |
| Kleck et al. | Production of Thermostable Hemolysin by Cultures of" Staphylococcus epidermidis" | |
| Murphy | Elastase production by oral staphylococci | |
| GB191414365A (en) | Improved Manufacture of Agents for Reducing Blood Pressure. | |
| ES465339A1 (en) | Inhibitors, obtained from bacilli, for glycoside hydrolases | |
| Jacobs et al. | Significance of deoxyribonuclease production by staphylococci | |
| FR2373544A1 (en) | NEW 7-O-ALKYLNOGAROLS, THEIR PREPARATION PROCESS AND MEDICINAL PRODUCTS CONTAINING THEM | |
| Dernby et al. | On the growth and the proteolytic enzymes of certain anaerobes | |
| Pollock | Penicillin‐induced resistance to penicillin in cultures of Bacillus cereus | |
| Bladen et al. | Lysis of certain organisms by the synergistic action of complement and lysozyme | |
| Hongo et al. | Characterization of a temperate phage and four bacteriocins produced by nonpathogenic Clostridium species | |
| Seow et al. | Modulation of human neutrophil adherence by periodontopathic bacteria: reversal by specific monoclonal antibodies | |
| Hopps et al. | Identification of tissue and bacterial hyaluronidase in human saliva | |
| RU94013100A (en) | Strain of lactobacillus helveticus tiii exhibiting capability to decreased blood serum cholesterol level | |
| Thonard et al. | Inhibition of a collagenase by the human gingival microbiota | |
| Fisk et al. | Digestion of casein by staphylococci on milk agar containing serum |